- Home
- AEI vs ICU Comparison
AEI vs ICU Comparison
Compare AEI & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- ICU
- Stock Information
- Founded
- AEI 2014
- ICU 2018
- Country
- AEI United States
- ICU United States
- Employees
- AEI N/A
- ICU N/A
- Industry
- AEI Building operators
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- AEI Real Estate
- ICU Health Care
- Exchange
- AEI Nasdaq
- ICU Nasdaq
- Market Cap
- AEI 10.7M
- ICU 10.4M
- IPO Year
- AEI N/A
- ICU N/A
- Fundamental
- Price
- AEI $0.84
- ICU $1.19
- Analyst Decision
- AEI
- ICU
- Analyst Count
- AEI 0
- ICU 0
- Target Price
- AEI N/A
- ICU N/A
- AVG Volume (30 Days)
- AEI 94.6K
- ICU 144.0K
- Earning Date
- AEI 05-15-2025
- ICU 05-14-2025
- Dividend Yield
- AEI N/A
- ICU N/A
- EPS Growth
- AEI N/A
- ICU N/A
- EPS
- AEI N/A
- ICU N/A
- Revenue
- AEI $16,097,995.00
- ICU $428,000.00
- Revenue This Year
- AEI N/A
- ICU $648.15
- Revenue Next Year
- AEI N/A
- ICU $100.00
- P/E Ratio
- AEI N/A
- ICU N/A
- Revenue Growth
- AEI N/A
- ICU N/A
- 52 Week Low
- AEI $0.70
- ICU $1.11
- 52 Week High
- AEI $2.61
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- AEI 37.30
- ICU 36.82
- Support Level
- AEI $0.77
- ICU $1.13
- Resistance Level
- AEI $0.85
- ICU $1.34
- Average True Range (ATR)
- AEI 0.06
- ICU 0.07
- MACD
- AEI -0.02
- ICU 0.00
- Stochastic Oscillator
- AEI 30.47
- ICU 28.57
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.